Furthermore, that mutant KRAS-driven MPE is attributed to a CCL2-dependent signalling cascade that is necessary for the sequential translocation of CD11b+Gr1+ cells from the bone marrow to the spleen and the tumour-involved pleural cavity, where, in turn, these cells promote MPE formation. This evidence concerns the gene CCL2 and neoplasm.